Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. (PLX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
plx · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Protalix BioTherapeutics, Inc. (PLX) has a market cap — also referred to as its net worth or valuation — of $157,920,418, making it one of the top most valuable companies globally. Market Cap = $1.96 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Protalix BioTherapeutics, Inc. (PLX) has a market cap — also referred to as its net worth or valuation — of $157,920,418 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Protalix BioTherapeutics, Inc. reached its all-time high market cap of $451,176,600 on Dec 31, 2016. Comparing the Protalix BioTherapeutics, Inc. market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Protalix BioTherapeutics, Inc. net worth vs peers and ask how Protalix BioTherapeutics, Inc. valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
PLX market cap · 6 questionsProtalix BioTherapeutics, Inc.'s net worth — measured as market capitalization — is $157,920,418 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$1.96 (price) × shares outstanding.